Mirae Asset Global ETFs Holdings
MRSN

Mirae Asset Global ETFs Holdings’s Mersana Therapeutics MRSN Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,750
Closed -$23.7K – 3155
2025
Q1 		$23.7K Buy
2,750
+113
+4% +$1.74K ﹤0.01% 2966
2024
Q4 		$94.3K Buy
2,637
+112
+4% +$5.79K ﹤0.01% 2726
2024
Q3 		$119K Buy
2,525
+247
+11% +$10.9K ﹤0.01% 2630
2024
Q2 		$114K Buy
+2,278
New +$165K ﹤0.01% 2503

Other funds holding MRSN

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's MRSN Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Mersana Therapeutics (MRSN) in Q2 2025, closing a stake of 2,750 shares — an estimated $23.7K sold.

Mirae Asset Global ETFs Holdings first reported a position in MRSN in Q2 2024 and held it in 4 quarters. The position peaked at $119K in Q3 2024. 83 funds tracked by Wall St. Rank hold MRSN as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Mersana Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 2,750 Mersana Therapeutics shares in Q2 2025, an estimated $23.7K.
  • Mirae Asset Global ETFs Holdings first reported a position in Mersana Therapeutics in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Mersana Therapeutics position peaked at $119K in Q3 2024.
  • 83 funds tracked by Wall St. Rank held Mersana Therapeutics as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.